IBD Breakout Opportunities ETF
ETFYour view on BOUT
IBD Breakout Opportunities ETF
ETFCapital ForceSentiment
AUM (USD)
$15.28M
Expense Ratio
0.8%
Holdings
27
Sentiment
Overview for IBD Breakout Opportunities ETF
- Fund Type
- ETF
- Fund Issuer
- Capital Force
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- September 13, 2018
- Domicile
- US
- Website
- capforceetf.com/BOUT/details
- Fund Type
- ETF
- Fund Issuer
- Capital Force
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- September 13, 2018
- Domicile
- US
- Website
- capforceetf.com/BOUT/details
- Fund Type
- ETF
- Fund Issuer
- Capital Force
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- September 13, 2018
- Domicile
- US
- Website
- capforceetf.com/BOUT/details
About this fund
The Innovator IBD Breakout Opportunities ETF seeks to provide exposure to the investment results of the IBD Breakout Stocks Index. The Index leverages decades of Investor's Business Daily research and seeks to identify stock breakout opportunities, or stocks poised to experience …
BOUT Stock Price
Key Facts
EquityExpense Ratio
0.8%
AUM
$15.28M
Fund Details
Expense Ratio
0.8%
Assets Under Management
$15.28M
NAV
$43.67 USD
Holdings
27
Average Volume
2.3K
Inception Date
September 13, 2018
Asset Class
Equity
Fund Issuer
Capital Force
Domicile
US
ISIN
US14016P1075
CUSIP
14016P107
NAV Currency
USD
Expense Ratio
0.8%
Assets Under Management
$15.28M
NAV
$43.67 USD
Holdings
27
Average Volume
2.3K
Inception Date
September 13, 2018
Asset Class
Equity
Fund Issuer
Capital Force
Domicile
US
ISIN
US14016P1075
CUSIP
14016P107
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.